{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:29:29Z","timestamp":1792654169836,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T00:00:00Z","timestamp":1305936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00198-011-1644-8","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T20:35:04Z","timestamp":1305923704000},"page":"2935-2949","source":"Crossref","is-referenced-by-count":46,"title":["Bone health in multiple sclerosis"],"prefix":"10.1007","volume":"22","author":[{"given":"J. C.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. D.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,21]]},"reference":[{"key":"1644_CR1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517","journal-title":"Lancet"},{"key":"1644_CR2","unstructured":"National Institute for Clinical Excellence (2003) Multiple sclerosis: management of multiple sclerosis in primary and secondary care. National Institute for Clinical Excellence, London"},{"key":"1644_CR3","doi-asserted-by":"crossref","unstructured":"Steffensen LH, Jorgensen L, Straume B, Mellgren SI, Kampman MT (2011) Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol (in press)","DOI":"10.1007\/s00415-011-5980-6"},{"key":"1644_CR4","unstructured":"Francis J, Gaywood I (2009) A cross-sectional study of bone health in multiple sclerosis"},{"key":"1644_CR5","first-page":"S79","volume":"8","author":"E Havrdova","year":"2002","unstructured":"Havrdova E, Tyblova M, Stepan JJ, Zikan V, Horakova D, Ticha V, Novakova I (2002) Osteoporosis in multiple sclerosis patients treated with corticosteroids. Mult Scler 8:S79","journal-title":"Mult Scler"},{"key":"1644_CR6","unstructured":"Hotermans C, Dive D, Rinkin, Leroy M, Malaise M, Moonen G, Franchimont N (2006) Hip bone mineral density is correlated with EDSS in patients with multiple sclerosis. J Neurol 257(3):410\u2013418"},{"key":"1644_CR7","first-page":"3","volume":"4","author":"E Gallagher","year":"2002","unstructured":"Gallagher E, Epstein S, Weppner D, Wrest K, Weinstock-Guttman B, Brownscheidle C, Patrick K, Jacobs L (2002) Bone loss in women with multiple sclerosis. International Journal of MS Care 4:3","journal-title":"International Journal of MS Care"},{"key":"1644_CR8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","volume":"51","author":"F Cosman","year":"1998","unstructured":"Cosman F, Nieves J, Komar L, Ferrer G, Herbert J et al (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161\u20131165","journal-title":"Neurology"},{"key":"1644_CR9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","volume":"9","author":"S Tuzun","year":"2003","unstructured":"Tuzun S, Altintas A, Karacan I, Tangurek S, Saip S, Siva A (2003) Bone status in multiple sclerosis: beyond corticosteroid. Mult Scler 9:600\u2013604","journal-title":"Mult Scler"},{"key":"1644_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","volume":"23","author":"S Ozgocmen","year":"2005","unstructured":"Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y (2005) Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 23:309\u2013313","journal-title":"J Bone Miner Metab"},{"key":"1644_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900309","volume":"61","author":"CA Formica","year":"1997","unstructured":"Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R (1997) Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int 61:129\u2013133","journal-title":"Calcif Tissue Int"},{"key":"1644_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","volume":"12","author":"M Zorzon","year":"2005","unstructured":"Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA, Cazzato G (2005) Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 12:550\u2013556","journal-title":"Eur J Neurol"},{"key":"1644_CR13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jocn.2010.01.044","volume":"17","author":"T Terzi","year":"2010","unstructured":"Terzi T, Terzi M, Tander B, Canturk F, Onar M (2010) Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci 17:1260\u20131264","journal-title":"J Clin Neurosci"},{"key":"1644_CR14","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/jc.2004-0164","volume":"89","author":"A Dovio","year":"2004","unstructured":"Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milano E, Bertolotto A, Angeli A (2004) Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 89:4923\u20134928","journal-title":"J Clin Endocrinol Metab"},{"key":"1644_CR15","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687\u20131692","journal-title":"Neurology"},{"key":"1644_CR16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","volume":"10","author":"B Weinstock-Guttman","year":"2004","unstructured":"Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, Miller C, Wrest K, Ramanathan M (2004) Risk of bone loss in men with multiple sclerosis. Mult Scler 10:170\u2013175","journal-title":"Mult Scler"},{"key":"1644_CR17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1682\/JRRD.2007.10.0159","volume":"45","author":"MC Mojtahedi","year":"2008","unstructured":"Mojtahedi MC, Snook EM, Motl RW, Evans EM (2008) Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition. J Rehabil Res Dev 45:851\u2013861","journal-title":"J Rehabil Res Dev"},{"key":"1644_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11845-008-0253-9","volume":"178","author":"M Shuhaibar","year":"2009","unstructured":"Shuhaibar M, McKenna MJ, Au-Yeong M, Redmond JM (2009) Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis. Ir J Med Sci 178:43\u201345","journal-title":"Ir J Med Sci"},{"key":"1644_CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1996.00550080071014","volume":"53","author":"SR Schwid","year":"1996","unstructured":"Schwid SR, Goodman AD, Edward PJ, McDermott MP, Mattson DH (1996) Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 53:753\u2013757","journal-title":"Arch Neurol"},{"key":"1644_CR20","first-page":"209","volume":"46","author":"AT El-Ghoneimy","year":"2009","unstructured":"El-Ghoneimy AT, Gad AH, Samir H, Shalaby NM (2009) Contribution of vitamin D to the pathogenesis of multiple sclerosis and its effect on bone. Egyptian Journal of Neurology, Psychiatry and Neurosurgery 46:209\u2013222","journal-title":"Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"1644_CR21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s001980070033","volume":"11","author":"DN Proctor","year":"2000","unstructured":"Proctor DN, Melton LJ, Khosla S, Crowson CS, O\u2019Connor MK, Riggs BL (2000) Relative influence of physical activity, muscle mass and strength on bone density. Osteoporos Int 11:944\u2013952","journal-title":"Osteoporos Int"},{"key":"1644_CR22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1053\/apmr.2002.35663","volume":"83","author":"CP Lambert","year":"2002","unstructured":"Lambert CP, Lee AR, Evans WJ (2002) Body composition in ambulatory women with multiple sclerosis. Arch Phys Med Rehabil 83:1559\u20131561","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cccn.2004.05.012","volume":"348","author":"JJ Stepan","year":"2004","unstructured":"Stepan JJ, Havrdova E, Tyblova M, Horakova D, Ticha V, Novakova I, Zikan V (2004) Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 348:147\u2013154","journal-title":"Clin Chim Acta"},{"key":"1644_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s004020000162","volume":"121","author":"D Sabo","year":"2001","unstructured":"Sabo D, Blaich S, Wenz W, Hohmann M, Loew M, Gerner HJ (2001) Osteoporosis in patients with paralysis after spinal cord injury. A cross sectional study in 46 male patients with dual-energy X-ray absorptiometry. Arch Orthop Trauma Surg 121:75\u201378","journal-title":"Arch Orthop Trauma Surg"},{"key":"1644_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-004-1665-7","volume":"16","author":"JM Slade","year":"2005","unstructured":"Slade JM, Bickel CS, Modlesky CM, Majumdar S, Dudley GA (2005) Trabecular bone is more deteriorated in spinal cord injured versus estrogen-free postmenopausal women. Osteoporos Int 16:263\u2013272","journal-title":"Osteoporos Int"},{"key":"1644_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00198-005-2028-8","volume":"17","author":"SD Jiang","year":"2006","unstructured":"Jiang SD, Dai LY, Jiang LS (2006) Osteoporosis after spinal cord injury. Osteoporos Int 17:180\u2013192","journal-title":"Osteoporos Int"},{"key":"1644_CR27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00198-005-1925-1","volume":"16","author":"MY Pang","year":"2005","unstructured":"Pang MY, Eng JJ, McKay HA, Dawson AS (2005) Reduced hip bone mineral density is related to physical fitness and leg lean mass in ambulatory individuals with chronic stroke. Osteoporos Int 16:1769\u20131779","journal-title":"Osteoporos Int"},{"key":"1644_CR28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s001980070103","volume":"11","author":"L Jorgensen","year":"2000","unstructured":"Jorgensen L, Jacobsen BK, Wilsgaard T, Magnus JH (2000) Walking after stroke: does it matter? Changes in bone mineral density within the first 12\u00a0months after stroke. A longitudinal study. Osteoporos Int 11:381\u2013387","journal-title":"Osteoporos Int"},{"key":"1644_CR29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF01626538","volume":"6","author":"PA Del","year":"1996","unstructured":"Del PA, Pappone N, Mandes MG, Mantova D, Scarpa R, Oriente P (1996) Determinants of bone mineral density in immobilization: a study on hemiplegic patients. Osteoporos Int 6:50\u201354","journal-title":"Osteoporos Int"},{"key":"1644_CR30","first-page":"296","volume":"91","author":"E Stenager","year":"1991","unstructured":"Stenager E, Jensen K (1991) Fractures in multiple sclerosis. Acta Neurol Belg 91:296\u2013302","journal-title":"Acta Neurol Belg"},{"key":"1644_CR31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.apmr.2007.10.043","volume":"89","author":"EW Peterson","year":"2008","unstructured":"Peterson EW, Cho CC, von KL, Finlayson ML (2008) Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil 89:1031\u20131037","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.42.7.1389","volume":"42","author":"RA Troiano","year":"1992","unstructured":"Troiano RA, Jotkowitz A, Cook SD, Bansil S, Zito G (1992) Rate and types of fractures in corticosteroid-treated multiple sclerosis patients. Neurology 42:1389\u20131391","journal-title":"Neurology"},{"key":"1644_CR33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.289.6443.501","volume":"189","author":"P Williams","year":"1984","unstructured":"Williams P, Frank A, Crawford CM et al (1984) Unrecongised femoral fractures in patients with paraplegia due to multiple sclerosis. Br Med J 189:501","journal-title":"Br Med J"},{"key":"1644_CR34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00005131-200403000-00011","volume":"18","author":"A Aggarwal","year":"2004","unstructured":"Aggarwal A, Parvizi J, Ganz R (2004) Bilateral spontaneous periacetabular fracture: an unusual complication of multiple sclerosis. J Orthop Trauma 18:182\u2013185","journal-title":"J Orthop Trauma"},{"key":"1644_CR35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.289.6440.309","volume":"289","author":"S Cocksedge","year":"1984","unstructured":"Cocksedge S, Freestone S, Martin JF (1984) Unrecognised femoral fractures in patients with paraplegia due to multiple sclerosis. Br Med J Clin Res Ed 289:309","journal-title":"Br Med J Clin Res Ed"},{"key":"1644_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apmr.2007.08.144","volume":"89","author":"WC Logan Jr","year":"2008","unstructured":"Logan WC Jr, Sloane R, Lyles KW, Goldstein B, Hoenig HM (2008) Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury. Arch Phys Med Rehabil 89:237\u2013243","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp.54.7.584","volume":"54","author":"WA Sibley","year":"1991","unstructured":"Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (1991) A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry 54:584\u2013589","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1644_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jech.2006.056622","volume":"62","author":"LJ Donaldson","year":"2008","unstructured":"Donaldson LJ, Reckless IP, Scholes S, Mindell JS, Shelton NJ (2008) The epidemiology of fractures in England. J Epidemiol Community Health 62:174\u2013180","journal-title":"J Epidemiol Community Health"},{"key":"1644_CR39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/WNL.0b013e3181beece8","volume":"73","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Cutter G, Tyry T, Vollmer T (2009) A cross-sectional study of bone health in multiple sclerosis. Neurology 73:1394\u20131398","journal-title":"Neurology"},{"key":"1644_CR40","first-page":"S450","volume":"21","author":"M Bazelier","year":"2010","unstructured":"Bazelier M, van Staa T, Leufkens H, Vestergaard P, Cooper C, Uitdehaag B, Lalmohamed A, de Vries F (2010) Risk of fracture in patients with multiple sclerosis: a population-based cohort study. Osteoporos Int 21:S450\u2013S451","journal-title":"Osteoporos Int"},{"key":"1644_CR41","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.apmr.2006.06.002","volume":"87","author":"ML Finlayson","year":"2006","unstructured":"Finlayson ML, Peterson EW, Cho CC (2006) Risk factors for falling among people aged 45 to 90\u00a0years with multiple sclerosis. Arch Phys Med Rehabil 87:1274\u20131279","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/apmr.2002.32825","volume":"83","author":"D Cattaneo","year":"2002","unstructured":"Cattaneo D, De NC, Fascia T, Macalli M, Pisoni I, Cardini R (2002) Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil 83:864\u2013867","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00002060-199409000-00004","volume":"73","author":"RL Kirby","year":"1994","unstructured":"Kirby RL, Ackroyd-Stolarz SA, Brown MG, Kirkland SA, MacLeod DA (1994) Wheelchair-related accidents caused by tips and falls among noninstitutionalised users of manually propelled wheelchairs in Nova Scotia. Am J Phys Med Rehabil 73:319\u2013330","journal-title":"Am J Phys Med Rehabil"},{"key":"1644_CR44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0269215508095087","volume":"23","author":"Y Nilsagard","year":"2009","unstructured":"Nilsagard Y, Lundholm C, Denison E, Gunnarsson LG (2009) Predicting accidental falls in people with multiple sclerosis\u2014a longitudinal study. Clin Rehabil 23:259\u2013269","journal-title":"Clin Rehabil"},{"key":"1644_CR45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/apmr.2002.32825","volume":"83","author":"D Cattaneo","year":"2002","unstructured":"Cattaneo D, DeNuzzo C, Fascia T, Macalli M, Pisoni I, Cardoni R (2002) Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil 83:864\u2013867","journal-title":"Arch Phys Med Rehabil"},{"key":"1644_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ageing\/17.6.365","volume":"17","author":"AJ Blake","year":"1988","unstructured":"Blake AJ, Morgan K, Bendall MJ, Dallosso H, Ebrahim SB, Arie TH, Fentem PH, Bassey EJ (1988) Falls by elderly people at home: prevalence and associated factors. Age Ageing 17:365\u2013372","journal-title":"Age Ageing"},{"key":"1644_CR47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/oxfordjournals.aje.a116681","volume":"137","author":"JL O\u2019Loughlin","year":"1993","unstructured":"O\u2019Loughlin JL, Robitaille Y, Boivin JF, Suissa S (1993) Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 137:342\u2013354","journal-title":"Am J Epidemiol"},{"key":"1644_CR48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","volume":"319","author":"ME Tinetti","year":"1988","unstructured":"Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701\u20131707","journal-title":"N Engl J Med"},{"key":"1644_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1682\/JRRD.2009.12.0192","volume":"48","author":"MH Cameron","year":"2011","unstructured":"Cameron MH, Poel AJ, Haselkorn JK, Linke A, Bourdette D (2011) Falls requiring medical attention among veterans with multiple sclerosis: a cohort study. J Rehabil Res Dev 48:13\u201320","journal-title":"J Rehabil Res Dev"},{"key":"1644_CR50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03343976","volume":"25","author":"P Ardissone","year":"2002","unstructured":"Ardissone P, Rota E, Durelli L, Limone P, Isaia GC (2002) Effects of high doses of corticosteroids on bone metabolism. J Endocrinol Investig 25:129\u2013133","journal-title":"J Endocrinol Investig"},{"key":"1644_CR51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jbmr.5650090718","volume":"9","author":"F Cosman","year":"1994","unstructured":"Cosman F, Nieves J, Herbert J, Shen V, Lindsay R (1994) High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 9:1097\u20131105","journal-title":"J Bone Miner Res"},{"key":"1644_CR52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-6-19","volume":"6","author":"FT Bergh","year":"2006","unstructured":"Bergh FT, Kumpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismuller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP (2006) Monthly intravenous methylprednisolone in relapsing\u2013remitting multiple sclerosis\u2014reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol 6:19","journal-title":"BMC Neurol"},{"key":"1644_CR53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","volume":"257","author":"LH Steffensen","year":"2010","unstructured":"Steffensen LH, Mellgren SI, Kampman MT (2010) Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol 257:410\u2013418","journal-title":"J Neurol"},{"key":"1644_CR54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1191\/1352458504ms1076oa","volume":"10","author":"A Achiron","year":"2004","unstructured":"Achiron A, Edelstein S, Ziev-Ner Y, Givon U, Rotstein Z, Barak Y (2004) Bone strength in multiple sclerosis: Cortical midtibial speed-of-sound assessment. Mult Scler 10:488\u2013493","journal-title":"Mult Scler"},{"key":"1644_CR55","first-page":"1083","volume":"31","author":"B Frediani","year":"2004","unstructured":"Frediani B, Falsetti P, Bisogno S, Baldi F, Acciai C, Filippou G, Bacarelli MR, Filipponi P, Galeazzi M, Marcolongo R (2004) Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol 31:1083\u20131087","journal-title":"J Rheumatol"},{"key":"1644_CR56","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Staa Van","year":"2003","unstructured":"Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229","journal-title":"Arthritis Rheum"},{"key":"1644_CR57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","volume":"98","author":"TP Staa Van","year":"2005","unstructured":"Van Staa TP, Geusens P, Pols HA, De LC, Leufkens HG, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM 98:191\u2013198","journal-title":"QJM"},{"key":"1644_CR58","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"key":"1644_CR59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008) Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 82:249\u2013257","journal-title":"Calcif Tissue Int"},{"key":"1644_CR60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP Staa Van","year":"2002","unstructured":"Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"1644_CR61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F Vries de","year":"2007","unstructured":"de Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208\u2013214","journal-title":"Arthritis Rheum"},{"key":"1644_CR62","unstructured":"Institute of Medicine of the National Academies (2010) Dietary reference intakes for calcium and vitamin D. In: Ross CA, Taylor AL, Yaktine AL, Del Valle HB (eds) National Academies Press, Washington, DC, p 1132"},{"key":"1644_CR63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/1352458504ms1006oa","volume":"10","author":"RD Simmons","year":"2004","unstructured":"Simmons RD, Ponsonby A-L, van der Mei IA, Sheridan P (2004) What affects your MS? Responses to an anonymous, internet-based epidemiological survey. Mult Scler 10:202\u2013211","journal-title":"Mult Scler"},{"key":"1644_CR64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp.2006.105320","volume":"79","author":"M Soilu-Hanninen","year":"2008","unstructured":"Soilu-Hanninen M, Laaksonen M, Laitinen I, Eralinna JP, Lilius EM, Mononen I (2008) A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 79:152\u2013157","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1644_CR65","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458509102844","volume":"15","author":"GS Hiremath","year":"2009","unstructured":"Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA (2009) Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Mult Scler 15:735\u2013740","journal-title":"Mult Scler"},{"key":"1644_CR66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00415-006-0315-8","volume":"254","author":"IA Mei van der","year":"2007","unstructured":"van der Mei IA, Ponsonby A-L, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254:581\u2013590","journal-title":"J Neurol"},{"key":"1644_CR67","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/1352458506072666","volume":"13","author":"MS Barnes","year":"2007","unstructured":"Barnes MS, Bonham MP, Robson PJ, Strain JJ, Lowe-Strong AS, Eaton-Evans J, Ginty F, Wallace JM (2007) Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult Scler 13:670\u2013672","journal-title":"Mult Scler"},{"key":"1644_CR68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1191\/1352458505ms1157oa","volume":"11","author":"M Soilu-Hanninen","year":"2005","unstructured":"Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266\u2013271","journal-title":"Mult Scler"},{"key":"1644_CR69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1352458508095920","volume":"15","author":"J Kragt","year":"2009","unstructured":"Kragt J, van AB, Killestein J, Dijkstra C, Uitdehaag B, Polman C, Lips P (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15:9\u201315","journal-title":"Mult Scler"},{"key":"1644_CR70","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale J, Ysrraelit MC, Gaitan MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132:1146\u20131160","journal-title":"Brain"},{"key":"1644_CR71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/BMR-2010-0244","volume":"23","author":"AO Varoglu","year":"2010","unstructured":"Varoglu AO, Varoglu E, Bayraktar R, Aygul R, Ulvi H, Yildirim K (2010) The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients. J Back Musculoskelet Rehabil 23:25\u201329","journal-title":"J Back Musculoskelet Rehabil"},{"key":"1644_CR72","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-009-1107-7","volume":"21","author":"IC Chang","year":"2010","unstructured":"Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21:1401\u20131409","journal-title":"Osteoporos Int"},{"key":"1644_CR73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","volume":"155","author":"MH Vogt","year":"2004","unstructured":"Vogt MH, Floris S, Killestein J, Knol DL, Smits M, Barkhof F, Polman CH, Nagelkerken L (2004) Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J Neuroimmunol 155:155\u2013160","journal-title":"J Neuroimmunol"},{"key":"1644_CR74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","volume":"158","author":"M Comabella","year":"2005","unstructured":"Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Blas NJ, Rio J, Montalban X (2005) Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 158:231\u2013239","journal-title":"J Neuroimmunol"},{"key":"1644_CR75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2008.08.031","volume":"276","author":"A Altintas","year":"2009","unstructured":"Altintas A, Saruhan-Direskeneli G, Benbir G, Demir M, Purisa S (2009) The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis? J Neurol Sci 276:41\u201344","journal-title":"J Neurol Sci"},{"key":"1644_CR76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/15246090050020709","volume":"9","author":"D Shabas","year":"2000","unstructured":"Shabas D, Weinreb H (2000) Preventive healthcare in women with multiple sclerosis. J Womens Health Gend-Based Med 9:389\u2013396","journal-title":"J Womens Health Gend-Based Med"},{"key":"1644_CR77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/j.2048-7940.2002.tb02020.x","volume":"27","author":"NC Sharts-Hopko","year":"2002","unstructured":"Sharts-Hopko NC, Sullivan MP (2002) Beliefs, perceptions, and practices related to osteoporosis risk reduction among women with multiple sclerosis. Rehabil Nurs 27:232\u2013237","journal-title":"Rehabil Nurs"},{"key":"1644_CR78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01376517-200408000-00004","volume":"36","author":"NC Sharts-Hopko","year":"2004","unstructured":"Sharts-Hopko NC, Smelter S (2004) Perceptions of women with multiple sclerosis about osteoporosis follow-up. J Neurosci Nurs 36:189\u2013194","journal-title":"J Neurosci Nurs"},{"key":"1644_CR79","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"1644_CR80","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","volume":"343","author":"C Confavreux","year":"2000","unstructured":"Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430\u20131438","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"1644_CR81","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1007\/s10072-003-0171-6","volume":"24","author":"M Trojano","year":"2003","unstructured":"Trojano M, Paolicelli D, Bellacosa A, Cataldo S (2003) The transition from relapsing-remitting MS to irreversible disability: clinical evaluation. Neurol Sci 24(Suppl 5):S268\u2013S270","journal-title":"Neurol Sci"},{"key":"1644_CR82","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awq076","volume":"133","author":"E Leray","year":"2010","unstructured":"Leray E, Yaouanq J, Le PE, Coustans M, Laplaud D, Oger J, Edan G (2010) Evidence for a two-stage disability progression in multiple sclerosis. Brain 133:1900\u20131913","journal-title":"Brain"},{"key":"1644_CR83","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/PHM.0b013e3181d3e71f","volume":"89","author":"BD Cakt","year":"2010","unstructured":"Cakt BD, Nacir B, Genc H, Saracoglu M, Karagoz A, Erdem HR, Ergun U (2010) Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil 89:446\u2013457","journal-title":"Am J Phys Med Rehabil"},{"key":"1644_CR84","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.0b013e3181bf98b4","volume":"73","author":"U Dalgas","year":"2009","unstructured":"Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K, Ingemann-Hansen T (2009) Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 73:1478\u20131484","journal-title":"Neurology"},{"key":"1644_CR85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7525-7-68","volume":"7","author":"NM Stroud","year":"2009","unstructured":"Stroud NM, Minahan CL (2009) The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes 7:68","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 2","key":"1644_CR86","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1093\/ageing\/afl084","volume":"35","author":"LZ Rubenstein","year":"2006","unstructured":"Rubenstein LZ (2006) Falls in older people: epidemiology, risk factors and strategies for prevention 1. Age Ageing 35(Suppl 2):ii37\u2013ii41","journal-title":"Age Ageing"},{"key":"1644_CR87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1545968308320641","volume":"23","author":"EM Snook","year":"2009","unstructured":"Snook EM, Motl RW (2009) Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair 23:108\u2013116","journal-title":"Neurorehabil Neural Repair"},{"key":"1644_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00198-006-0293-9","volume":"18","author":"HA Bischoff-Ferrari","year":"2007","unstructured":"Bischoff-Ferrari HA (2007) How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18:401\u2013407","journal-title":"Osteoporos Int"},{"key":"1644_CR89","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11255-009-9551-z","volume":"41","author":"C Musso","year":"2009","unstructured":"Musso C, Liakopoulos V, Pangre N, DiTrolio J, Jauregui R, De MR, Stefanidis I, Imperiali N, Algranati L (2009) Renal physiology in elderly persons with severe immobility syndrome. Int Urol Nephrol 41:437\u2013441","journal-title":"Int Urol Nephrol"},{"key":"1644_CR90","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000014510.48897.7D","volume":"33","author":"KE Poole","year":"2002","unstructured":"Poole KE, Reeve J, Warburton EA (2002) Falls, fractures, and osteoporosis after stroke: time to think about protection? Stroke 33:1432\u20131436","journal-title":"Stroke"},{"key":"1644_CR91","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.20825","volume":"21","author":"Y Sato","year":"2006","unstructured":"Sato Y, Iwamoto J, Kanoko T, Satoh K (2006) Alendronate and vitamin D2 for prevention of hip fracture in Parkinson\u2019s disease: a randomized controlled trial. Mov Disord 21:924\u2013929","journal-title":"Mov Disord"},{"key":"1644_CR92","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1352458509358089","volume":"16","author":"M Poorjavad","year":"2010","unstructured":"Poorjavad M, Derakhshandeh F, Etemadifar M, Soleymani B, Minagar A, Maghzi AH (2010) Oropharyngeal dysphagia in multiple sclerosis. Mult Scler 16:362\u2013365","journal-title":"Mult Scler"},{"key":"1644_CR93","first-page":"5","volume":"2","author":"RM Herndon","year":"2000","unstructured":"Herndon RM, Mohandas N (2000) Osteoporosis in multiple sclerosis: a frequent, serious, and under-recognized problem. In J MS Care 2:5\u201312","journal-title":"In J MS Care"},{"key":"1644_CR94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1615\/JEnvironPatholToxicolOncol.v29.i1.20","volume":"29","author":"RF Edlich","year":"2010","unstructured":"Edlich RF, Mason SS, Reddig JS, Gubler K, Long WB III (2010) A case report: femoral fracture in a multiple sclerosis patient with vitamin D deficiency\u2014a preventable injury. J Environ Pathol Toxicol Oncol 29:3\u20135","journal-title":"J Environ Pathol Toxicol Oncol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1644-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1644-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T01:17:32Z","timestamp":1560215852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1644-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,21]]},"references-count":94,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1644-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,21]]}}}